A Comparison of Results of the US Food and Drug Administration’s Mini-Sentinel Program With Randomized Clinical Trials-Reference-Cited by-同舟云学术

A Comparison of Results of the US Food and Drug Administration’s Mini-Sentinel Program With Randomized Clinical Trials

Published:2014-01-01 Issue:1 Volume:174 Page:150
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Sipahi Ilke¹,Celik Seden²,Tozun Nurdan³

Affiliation:

1. Department of Cardiology, Acibadem University Medical School, Istanbul, Turkey2Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio

2. Department of Cardiology, Acibadem University Medical School, Istanbul, Turkey

3. Department of Internal Medicine, Acibadem University Medical School, Istanbul, Turkey

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of dabigatran;Glavvrač (Chief Medical Officer);2024-01-22

2. A Historical Perspective on the Reversal of Anticoagulants;Seminars in Thrombosis and Hemostasis;2022-09-02

3. Time Trends and Treatment Pathways in Prescribing Individual Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: An Observational Study of More than Three Million Patients from Europe and the United States;International Journal of Clinical Practice;2022-01-31

4. Safety of Dabigatran as an Anticoagulant: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-02-02

5. Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources;Journal of the American Medical Informatics Association;2019-11-26